Short-term Beneficial Effect of Aspirin in Patient with Chronic Rhinosinusitis and Tolerant to Acetylsalicylic Acid
Abstract
It is well known that desensitization treatment with aspirin can significantly improve symptoms and quality of life in patient with aspirin-exacerbated respiratory disease. However, its mechanism has not been clearly understood yet. In this case report, 41-year-old male patient was referred to our allergy and immunology department with complaints of chronic rhinosinusitis including postnasal discharge, sneezing, facial pain/pressure, waking up tired, nasal obstruction, smell loss for a long time. According to the patient, the complaints were controlled partially with nasal steroid and antihistamines, and single dose parenteral depot steroids were highly effective in controlling the symptoms and each time this effect lasted at least three weeks.
The patient was told to use aspirin when needed analgesic and he started to use aspirin 500 mg bid. po for 10 days for his pain in the joints. The patient stressed the superiority of aspirin over other drugs including oral antihistamine and LTA and its equality to systemic steroid drugs in suppressing symptoms. It seemed that aspirin had positive effects in allergic inflammation at least in some subset of aspirin tolerant patients with chronic sinusitis.
1. Berges-Gimeno MP, Simon RA, Stevenson DD. Long- term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111(1):180-6.
2. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis- asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98:751-8.
3. Stevenson DD, Simon RA. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006; 118(4):801-4.
4. Merkonidis C, Gudziol V, Cecchini MP, Gerber J, Seo HS, Bachert C, et al. Improvement of chronic rhinitis under aspirin. Respir Care 2012; 57(3):460-3.
5. Katial RK, Strand M, Prasertsuntarasai T, Leung Z, Zheng W, Alarm R. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol 2010; 126(4):738-44.
6. Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD.Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999; 104 (3 Pt 1):559-64.
7. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin- sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
8. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL.Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Immunol 1995;96:148-56.
9. 9.Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH.Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347:1524-6.
10. Lee RU, Stevenson DD. Aspirin-Exacerbated Respiratory Disease: Evaluation and Management. Allergy Asthma Immunol Res 2011; 3(1):3-10.
Moneret-Vautrin DA, Hsieh V, Wayoff M, Guyot JL, Mouton C, Maria Y. Nonallergic rhinitis with eosinophilia syndrome a precursor of the trial: nasal polyposis, intrinsicasthma, and intolerance to aspirin. Ann Allergy 1990; 64(6):513-8
Files | ||
Issue | Vol 12, No 4 (2013) | |
Section | Articles | |
Keywords | ||
Acetylsalicylic acid Allergy Aspirin Chronic rhinosinusitis Corticosteroids Nasal polyps |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |